Rivaroxaban API Manufacturers

Looking for Rivaroxaban API 366789-02-8?

Description:

Here you will find a list of producers, manufacturers and distributors of Rivaroxaban. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.

API | Excipient name:

Rivaroxaban 

Synonyms:

Xarelto  

Cas Number:

366789-02-8 

DrugBank number:

DB06228 

Unique Ingredient Identifier:

9NDF7JZ4M3

Rivaroxaban is a type of Antithrombotics

Antithrombotics, a subcategory of pharmaceutical active pharmaceutical ingredients (APIs), play a crucial role in preventing and treating thrombotic disorders, which are characterized by the formation of blood clots within blood vessels. These medications are essential in reducing the risk of thrombosis, such as deep vein thrombosis (DVT), pulmonary embolism (PE), and stroke, which can lead to severe health complications.

Antithrombotics exert their therapeutic effects through various mechanisms. One commonly used class of antithrombotics is anticoagulants, which inhibit the clotting process by interfering with the formation of blood clots. These drugs include heparin, warfarin, and direct oral anticoagulants (DOACs). They are administered to patients with conditions like atrial fibrillation, venous thromboembolism, or mechanical heart valves to prevent clot formation.

Another class of antithrombotics is antiplatelet agents, which prevent platelet aggregation, an essential step in blood clot formation. Aspirin, clopidogrel, and ticagrelor are well-known antiplatelet drugs used to prevent thrombosis in patients with coronary artery disease, ischemic stroke, or peripheral artery disease.

Antithrombotics are typically prescribed based on the individual patient's risk factors, medical history, and the specific thrombotic condition being treated. Dosage and administration instructions may vary depending on the drug's pharmacokinetic profile and desired therapeutic outcomes.

As with any medication, antithrombotics may have potential side effects, such as increased bleeding risk. Therefore, healthcare professionals carefully assess the patient's overall health status, including any underlying conditions, before prescribing these medications.

In conclusion, antithrombotics are a crucial subcategory of pharmaceutical APIs that play a vital role in preventing and treating thrombotic disorders. By inhibiting clot formation through various mechanisms, these medications significantly contribute to reducing the risk of serious complications associated with blood clots.

Rivaroxaban (Antithrombotics), classified under Anticoagulants

Anticoagulants are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used to prevent and treat blood clotting disorders. These medications play a crucial role in various medical conditions, including deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF). Anticoagulants work by inhibiting the formation of blood clots or by preventing existing clots from getting larger.

There are different types of anticoagulants available, including direct thrombin inhibitors, vitamin K antagonists, and factor Xa inhibitors. Direct thrombin inhibitors, such as dabigatran, directly target the enzyme thrombin to hinder clot formation. Vitamin K antagonists, like warfarin, interfere with the production of clotting factors that rely on vitamin K. Factor Xa inhibitors, such as rivaroxaban and apixaban, inhibit the activity of factor Xa, a crucial component in the clotting cascade.

Anticoagulants are commonly prescribed to patients at risk of developing blood clots or those with existing clotting disorders. They are often used during surgeries, such as hip or knee replacements, to minimize the risk of post-operative clot formation. Patients with AF, a condition characterized by irregular heart rhythm, may also be prescribed anticoagulants to prevent stroke caused by blood clots.

While anticoagulants offer significant benefits in preventing and treating clot-related conditions, they also carry potential risks, including bleeding complications. Patients taking anticoagulants require careful monitoring to ensure the right dosage is administered, as excessive anticoagulation can lead to hemorrhage. Regular blood tests and close medical supervision are essential to manage the delicate balance between preventing clots and avoiding excessive bleeding.

In conclusion, anticoagulants are a crucial category of pharmaceutical APIs used to prevent and treat blood clotting disorders. They function by inhibiting clot formation or preventing existing clots from enlarging. While highly beneficial, their use requires careful monitoring to minimize the risk of bleeding complications.

• Sinoway industrial Co.,Ltd from China, product country of origin China
• Polpharma from Poland, product country of origin Poland
• Morepen Laboratories Ltd. from India, product country of origin India
• PluviaEndo from Turkey, product country of origin Turkey
• Jubilant Pharmova from India, product country of origin India
• Suanfarma from Spain, product country of origin Spain
• Apino Pharma Co., Ltd. from China, product country of origin China
• Rochem International, Inc. from United States, product country of origin United States
• Aurora Industry Co., Ltd from China, product country of origin China
• AXXO GmbH from Germany, product country of origin World
• SETV Global from India, product country of origin India
• Gedeon Richter from Hungary, product country of origin Hungary
• Shandong Boyuan from China, product country of origin China
• Unichem Labs. from India, product country of origin India
• Flavine from Germany, product country of origin Unknown
• Symed Labs from India, product country of origin India
• Zhejiang Supor from China, product country of origin China
• Zhejiang Changming from China, product country of origin China
• Srini Pharma from India, product country of origin India
• Cambrex from Italy, product country of origin United States
• Qilu Antibiotics from China, product country of origin China
• Intas Pharma from United Kingdom, product country of origin Unknown
• Raks Pharma from India, product country of origin India
• Amino Chemicals from Malta, product country of origin Malta
• Weijie Pharmaceuticals from China, product country of origin China
• Menovo from China, product country of origin China
• KRKA from Slovenia, product country of origin Slovenia
• Vasudha Pharma Chem Ltd. from India, product country of origin India
• Zhejiang Charioteer from China, product country of origin China
• Dr. Reddy's from India, product country of origin India
• Quimica Sintetica from Spain, product country of origin Spain
• Kinsy from Spain, product country of origin Spain
• HEC Pharm from Germany, product country of origin Unknown
• Farmak from Czech Republic, product country of origin Czech Republic
• ZCL Chemicals from India, product country of origin India
• Moehs from Spain, product country of origin Spain
• Piramal Pharma Solutions from India, product country of origin India
• Lupin from India, product country of origin India
• Optimus Drugs Pvt Ltd from India, product country of origin India
• Medichem from Spain, product country of origin Malta
• Micro Labs from India, product country of origin India
• MSN Labs. from India, product country of origin India
• Bayer from Germany, product country of origin Unknown
• Shaoxing Hantai Pharma from China, product country of origin China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.